X

Insurers engage in FDA program to accelerate medical device coverage

Several healthcare insurers have reportedly decided to participate in a new-fangled federal government program intended…

Ojaswita Kutepatil

WUSTL’s revolutionary technique to enable drug delivery to the brain

St. Louis based Washington University’s researchers have reportedly established a new technique to overcome the…

Ojaswita Kutepatil

EU provides the long-awaited green signal for Merck’s Keytruda

One of the largest pharmaceutical companies in the world, Merck & Co has reportedly gained…

Ojaswita Kutepatil

AstraZeneca & Amgen’s tezepelumab crowned with ‘breakthrough’ status

The tezepelumab therapy produced by pharmaceutical giants AstraZeneca and Amgen, has reportedly won the status…

Ojaswita Kutepatil

NICE rejects Roche’s expensive rare multiple sclerosis drug Ocrevus

Roche, a Swiss multinational healthcare company, has reportedly made it to the headlines with regards…

Shikha Sinha

Glenmark Pharma’s arm to launch a generic asthma drug in Germany

India’s leading pharmaceutical company, Glenmark Pharmaceuticals Ltd, has reportedly announced that its subsidiary has acquired…

Ojaswita Kutepatil

Aterica to launch Veta Smart Case & App for epinephrine auto-injectors

Aterica Inc., a renowned digital health company based in Waterloo, Canada, has recently announced the…

Ojaswita Kutepatil

Hospitals to counter rising prices by launching generic drug company

Intermountain Healthcare, headquartered in Salt Lake City, Utah, has officially announced the launch of Civica…

Ojaswita Kutepatil

Aurobindo Pharma buys U.S. dermatology & oral solid business of Sandoz

Aurobindo Pharma, the second-biggest drugmaker in India, recently announced that it has agreed to buy…

Shikha Sinha